Highly Innovative Drug Program in the Czech Republic: Description and Pharmacoeconomic Results—Cost-Effectiveness and Budget Impact Analyses-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Highly Innovative Drug Program in the Czech Republic: Description and Pharmacoeconomic Results—Cost-Effectiveness and Budget Impact Analyses

Published:2018-09 Issue: Volume:16 Page:92-98
ISSN:2212-1099
Container-title:Value in Health Regional Issues
language:en
Short-container-title:Value in Health Regional Issues

Author:

Ornstova Eva,Sebestianova Monika,Mlcoch Tomas,Lamblova Klara,Dolezal Tomas

Publisher

Elsevier BV

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Reference19 articles.

1. International Society for Pharmacoeconomics and Outcomes Research.Pharmacoeconomic guidelines around the world. Available from: https://www.ispor.org/PEguidelines/index.asp, [Accessed February 4, 2018].

2. Assessing the value of drugs for rare conditions;Ollendorf,2017

3. Assessment of medicines for very rare conditions: review of a new approach within the Scottish Medicines Consortium;Jones,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Framework for developing cost-effectiveness analysis threshold: the case of Egypt;Journal of the Egyptian Public Health Association;2024-06-03

2. Novel approach to decision making for orphan drugs;International Journal of Technology Assessment in Health Care;2023

3. Drug Policy Research and Health Technology Assessment in Central and Eastern Europe, Western Asia, and Africa: The Interface Between Research Evidence, Policy, and Practice;Value in Health Regional Issues;2018-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP